Drug Database
Back to search

United States· US:0093-8076_2a8d7987-54ae-45d7-8224-361dac37e0a4

Tiagabine Hydrochloride

A tiagabine product containing tiagabine hydrochloride, registered in United States by Teva Pharmaceuticals USA, Inc.. The same ATC class is registered in 9 of our 19 countries.

ATC N03AG06US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedTiagabine HydrochlorideATCN03AG06REGISTER NO.US:0093-8076_2a8d7987…PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about tiagabine hydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Tiagabine is registered in 9 of 19 countries.

Countries holding a registration under ATC N03AG06 (tiagabine), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 7 of them publish a price we can compare per daily dose
Search tiagabine products by name

Tiagabine · ATC N03AG06

9 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Franceprice
  • Ireland
  • Italyprice
  • Norwayprice
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of tiagabine costs, country by country.

Normalised to the WHO defined daily dose (30 mg), so markets compare like for like.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Tiagabine · price per daily dose (30 mg)

USD · FX 28 Sept 2026

  • IT Italy$3.98
  • FR France$3.35
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
TIAGABINE HYDROCHLORIDE
Manufacturer
Teva Pharmaceuticals USA, Inc.
Country
United States (US)
ATC code
N03AG06
ATC class
Tiagabine
Defined daily dose
30 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    0093807656
    30 TABLET, FILM COATED in 1 BOTTLE (0093-8076-56)
  • ndc11
    0093-8076-56

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

163 interactions on record for tiagabine.

Graded by severity as the source publishes them — 92 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check tiagabine against other medicinesHow interaction checks work

Tiagabine · interactions on record

163 records

  • 92 moderate
  • 46 info

Most severe, free to view

  • MetoclopramideA03FA01moderate
  • DiphenhydraminA04AB05moderate
  • DronabinolA04AD10moderate
  • NabiloneA04AD11moderate

25 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Tiagabine in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tiagabine products

Authorised across Europe · EMA

The same active substance is authorised in 9 EEA countries. Names it is sold under:

  • Belgium · Gabitril
  • Spain · Gabitril
  • France · Gabitril
  • United Kingdom (Northern Ireland) · Gabitril
  • Ireland · Gabitril
  • Italy · Gabitril
  • Luxembourg · Gabitril
  • Poland · Gabitril
  • Portugal · Gabitril

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/de4b6f72-38f1-4ac3-b653-92a6b85e7259
GET /v1/drugs/de4b6f72-38f1-4ac3-b653-92a6b85e7259?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "16",
  "substance": "TIAGABINE HYDROCHLORIDE",
  "productndc": "0093-8076",
  "dosage_form": "TABLET, FILM COATED",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "NDA020646",
  "marketing_category": "NDA AUTHORIZED GENERIC"
}
API referenceMCP serverPlans

See everything about tiagabine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console